Amendment to Employment Agreement between Homology Medicines, Inc. and Michael Blum
Homology Medicines, Inc. and Michael Blum have agreed to amend their existing employment agreement, effective September 6, 2022. The amendment changes the severance terms, specifying that if Michael Blum separates from the company, he will receive a cash payment equal to one year's base salary, paid in regular installments over 12 months. All other terms of the original agreement remain unchanged. This amendment is governed by Massachusetts law and supersedes any prior agreements on this subject.
Exhibit 10.5
HOMOLOGY MEDICINES, INC.
AMENDMENT TO EMPLOYMENT AGREEMENT
This AMENDMENT TO EMPLOYMENT AGREEMENT (this “Amendment”) is entered into effective as of September 6, 2022, by and between Homology Medicines, Inc. (the “Company”) and Michael Blum (“Executive,” and, together with the Company, the “Parties”).
WHEREAS, the Parties entered into the Employment Agreement, dated as of September 1, 2021 (the “Agreement”); and
NOW, THEREFORE, in consideration of the promises, mutual covenants, and the agreements herein set forth, and for other good and valuable consideration, the sufficiency of which is hereby acknowledged, the Parties hereby agree as follows:
“(i) an amount in cash equal to 1.0 times the Annual Base Salary, payable in the form of salary continuation in regular installments over the 12-month period following the date of Executive’s Separation from Service (the “Severance Period”) in accordance with the Company’s normal payroll practices.”
(Signature page follows)
IN WITNESS WHEREOF, the Parties have each duly executed this AMENDMENT TO EMPLOYMENT AGREEMENT effective as of the date and year first written above.
HOMOLOGY MEDICINES, INC. |
By: /s/ Paul Alloway |
Name: Paul Alloway |
Title: Chief Legal Officer |
EMPLOYEE: |
/s/ Michael Blum |
Name: Michael Blum |